Hair Loss Ruins Your Mind: 10x rate of BDD. PF S is not real
    Research/Science 2/6/2026

    From the encyclopedia
    Finasteride →

    Popular 5-alpha reductase inhibitor that lowers DHT, taken as a pill or used topically

    Dutasteride →

    5-alpha reductase inhibitor that blocks both enzyme types, a stronger DHT blocker than finasteride

    Minoxidil →

    Vasodilator used on the scalp and, at low doses, as a tablet

    At a glance
    In this educational post, the primary subjects mentioned are the tone is 😐 neutral.

    Other terms

    Hair loss is linked to a higher rate of body dysmorphic disorder (BDD), OCD, and depression. Finasteride and dutasteride are not linked to increased suicidal risk, though some users report mental health side effects.
    View this post in the Community →

    Similar Community Posts Join

    5 / 5 results

      community Hair Loss Causes Depression. Not Finasteride.

       187 upvotes 7 months ago
      Finasteride and Dutasteride do not cause depression or mood disorders; hair loss itself may be a more significant factor. Some users experience side effects from Finasteride, but it is generally well-tolerated.

      community Suffer so bad I want it to end

      in Chat  111 upvotes 1 year ago
      A 23-year-old is distressed about hair loss despite using dutasteride and oral minoxidil and is considering a hair transplant in Turkey. Many suggest therapy, hair systems, or acceptance, emphasizing mental health over appearance.

      community EU Shouldn't Ban Fin & Dut: PFS is NOT REAL.

       10 upvotes 1 year ago
      Finasteride and Dutasteride do not cause depression or "Post Finasteride Syndrome," with concerns often linked to the nocebo effect and preexisting mental health issues. The EU is unlikely to ban these drugs, but access may become more restricted due to ongoing debates.

      community DUPA, Non Responders and Connective Tissue Disorders

       8 upvotes 1 year ago
      A 27-year-old male with diffuse hair loss, including the donor area, did not respond to finasteride, dutasteride, or minoxidil. He suspects his hair loss may be linked to a mild connective tissue disorder, possibly affecting the structural support of hair follicles, rather than being purely hormonal.

    Related Research

    6 / 6 results

      research Obsessive-compulsive disorder in dermatology

      15 citations , September 2015 in “Journal der Deutschen Dermatologischen Gesellschaft”
      This review discusses OCD spectrum disorders with dermatological symptoms, emphasizing their clinical features, neurobiology, and treatment options, while noting the need for more controlled studies.

      research Letters to the Editors

      November 2012 in “Hair transplant forum international”
      This article discusses Dr. Rajput's study on body dysmorphic disorder in hair loss patients and their improvement post-hair restoration, but it presents no original findings itself.

      research Avoiding pitfalls in planning a hair transplant

      July 2008 in “Expert Review of Dermatology”
      This review discusses common mistakes in follicular unit transplantation and provides guidance for practitioners to enhance patient outcomes, but reports no new clinical results.

      research Psychodermatology

      25 citations , January 2015 in “Advances in Psychosomatic Medicine”
      This review discusses common psychodermatologic conditions and provides practical diagnostic and therapeutic recommendations but reports no new results; the authors emphasize the challenge of treating patients who lack insight into their psychiatric symptoms.

      research Somatization in the dermatology patient: Some sociocultural perspectives

      5 citations , January 2017 in “Clinics in Dermatology”
      This review discusses the challenges of diagnosing and managing somatization in dermatology patients, highlighting the need for comprehensive evaluation of unexplained dermatologic symptoms, and reports no new results.